G71.00

Clinical Causes: Genetic mutations: most muscular dystrophies are inherited through defective genes that interfere with muscle protein production. Family history: individuals with relatives diagnosed with muscular dystrophy are at higher risk. De novo mutations: new genetic mutations can occur spontaneously without a prior family history. X-linked inheritance: certain types, like Duchenne and Becker muscular dystrophy, are linked to X chromosomes, primarily affecting males.

Key Symptoms: Muscle weakness, often starting in the hips, pelvis, thighs, or shoulders Progressive loss of muscle mass Difficulty with mobility, such as walking, running, or climbing stairs Muscle cramps and stiffness Gait abnormalities, like a waddling walk or toe-walking Delayed motor skills development in children Breathing difficulties in advanced stages due to weakened respiratory muscles Heart problems, including cardiomyopathy, in some types

Diagnosis Path: Medical history review and physical examination to assess muscle strength and function Blood tests measuring muscle enzymes like creatine kinase (CK), which tend to be elevated Genetic testing to identify specific gene mutations Electromyography (EMG) to evaluate electrical activity in muscles Muscle biopsy for histological analysis to observe muscle tissue abnormalities Imaging studies, such as MRI, to assess muscle tissue integrity Cardiac evaluations if heart involvement is suspected

Treatment Protocols: Physical therapy aimed at preserving muscle strength and flexibility Occupational therapy to assist with daily activities and mobility aids Respiratory support, including ventilatory assistance if breathing is compromised Medications to manage symptoms, such as corticosteroids to slow muscle degeneration Assistive devices like braces, walkers, or wheelchairs for mobility support Cardiac care for associated heart conditions Regular monitoring by healthcare professionals to tailor management plans